CTRI/2013/03/003494Completed未知
Comparison of Intravenous Fluids with Early Administration of Nasojejunal Feeds: A Randomized Trial assessing the Feasibility & Impact on the Course, Complications and Outcome of Acute Severe Pancreatitis.
Prof DK Bhasin0 sites100 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •All acute severe pancreatitis on admission
Exclusion Criteria
- •1. Patients who are already on or fit to be on oral diet
- •2. Patients who have mild disease.
- •3. Critically ill patients who cannot undergo endoscopic guided tube placement.
Investigators
Similar Trials
Completed
Phase 2
Effect of intravenous fluid sodium concentration on plasma sodium in pediatric patientsHyponatremia.Hypo-osmolality and HyponatremiaIRCT2013121015740N1Vice chancellor for research, Tehran Univercity of Medcal Sciences100
Completed
Phase 3
Investigation and comparison of intravenous infusion of sodium pentotal on the neurological outcomes of patients undergoing decompressive craniectomyCraniocerebral Trauma.Traumatic cerebral edema with loss of consciousness of any duration with death due to brain injury prior to regaining consciousness, initial encounterS06.1X7AIRCT20200817048436N1Ahvaz University of Medical Sciences50
Completed
Not Applicable
Evaluation of enteral administration of fat in very low birth weight infantsprematurity.Less than 28 completed weeks (less than 196 completed days) of gestation.IRCT201310164113N5Peiatric Health Research Center of Tabriz78
Completed
Not Applicable
Comparison of the effect of two balanced crystalloid intraoperative (iv) solutions ( plasmalyte vs sterofundin) on lactate levels during major cancer surgeries.CTRI/2020/10/028716Rajiv Gandhi cancer institute
Completed
Not Applicable
Phase 1 comparative study of intravenous formulation of acetaminophen and oral formulation of acetaminopheHealthy male subjectsJPRN-UMIN000005923Terumo Corporation20